Literature DB >> 14352118

An extrapyramidal syndrome with reserpine.

A RICHMAN, J S TYHURST.   

Abstract

Entities:  

Keywords:  RAUWOLFIA ALKALOIDS/injurious effects

Mesh:

Substances:

Year:  1955        PMID: 14352118      PMCID: PMC1825448     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Clinical and experimental effects of reserpine in patients with essential hypertension.

Authors:  E D FREIS; R ARI
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

2.  Clinical usage of Rauwolfia alkaloids, including reserpine (serpasil).

Authors:  R W WILKINS
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

  2 in total
  7 in total

1.  Rauwolfia alkaloids in mental syndromes.

Authors:  H AZIMA; I KENT; R A CLEGHORN
Journal:  Can Med Assoc J       Date:  1955-12-01       Impact factor: 8.262

2.  Use of reserpine and Rauwolfia in psychoneuroses.

Authors:  A FOLKSON; A R MAY
Journal:  Br Med J       Date:  1955-11-05

Review 3.  The vesicular monoamine transporter 2: an underexplored pharmacological target.

Authors:  Alison I Bernstein; Kristen A Stout; Gary W Miller
Journal:  Neurochem Int       Date:  2014-01-04       Impact factor: 3.921

Review 4.  Vesicular integrity in Parkinson's disease.

Authors:  Shawn P Alter; Gina M Lenzi; Alison I Bernstein; Gary W Miller
Journal:  Curr Neurol Neurosci Rep       Date:  2013-07       Impact factor: 5.081

5.  Dangers in the use of some potent drugs.

Authors:  W B SPAULDING
Journal:  Can Med Assoc J       Date:  1962-12-15       Impact factor: 8.262

6.  [The Rauwolfia alkaloid, reserpine (serpasil) in psychiatry].

Authors:  F A MIELKE
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1956

Review 7.  Parkinson's disease, dopaminergic drugs and the plant world.

Authors:  Peter Kempster; Andrew Ma
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.